| Item Type | Name |
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
Small Cell Lung Carcinoma
|
|
Concept
|
Lung
|
|
Academic Article
|
Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response.
|
|
Academic Article
|
Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients.
|
|
Academic Article
|
Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
|
|
Academic Article
|
PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
|
|
Academic Article
|
Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer.
|
|
Academic Article
|
Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis.
|
|
Academic Article
|
Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution.
|
|
Academic Article
|
Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.
|
|
Academic Article
|
Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer.
|
|
Academic Article
|
Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival.
|
|
Academic Article
|
The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib.
|
|
Academic Article
|
Treatment of locally advanced non-small cell lung cancer.
|
|
Academic Article
|
Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer.
|
|
Academic Article
|
PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy.
|
|
Academic Article
|
Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls.
|
|
Academic Article
|
Utility of insulin-like growth factor receptor-1 expression in gefitinib-treated patients with non-small cell lung cancer.
|
|
Academic Article
|
Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy.
|
|
Academic Article
|
Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung.
|
|
Academic Article
|
Survival Prediction in Ambulatory Patients With Stage III/IV Non-Small Cell Lung Cancer Using the Palliative Performance Scale, ECOG, and Lung Cancer Symptom Scale.
|
|
Academic Article
|
Treatment of advanced squamous cell carcinoma of the lung: a review.
|
|
Academic Article
|
Immunotherapy to overcome lung tumor cell-induced escape from immunosurveillance.
|
|
Academic Article
|
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer.
|
|
Academic Article
|
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
|
|
Academic Article
|
Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy.
|
|
Academic Article
|
Practical and theoretical implications of weight gain in advanced non-small cell lung cancer patients.
|
|
Academic Article
|
The serum-based VeriStrat? test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients.
|
|
Academic Article
|
Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC).
|
|
Academic Article
|
Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1-Expressing NSCLC.
|
|
Academic Article
|
Theoretical and Practical Implications of Treating Cachexia in Advanced Lung Cancer Patients.
|
|
Academic Article
|
Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition.
|
|
Academic Article
|
Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy.
|
|
Academic Article
|
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry.
|
|
Academic Article
|
Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial.
|
|
Academic Article
|
Sexual Health Assessment in Women with Lung Cancer study: Sexual health assessment in women with lung cancer.
|
|
Academic Article
|
Four-Phase, Definitive Chemoradiation for a Real-World (Poor Risk and/or Elderly) Patient Population With Locally Advanced Non-small Cell Lung Cancer.
|